Considerations for AMR in the Covid-19 pandemic

  17 April 2020

The Covid-19 pandemic reinforces the importance of preventative measures such as vaccination and antimicrobial treatments in maintaining human health. Similarly, controlling infectious agents is necessary to sustain the global economy and societal functionality. Bacterial co-infections are a significant cause of morbidity and mortality during viral infections and are already being reported as having a significant impact in the context of Covid-19.

The Covid-19 pandemic highlights the need to understand the complex connections between bacterial and viral infections. It is important to consider that patients in countries that have used high levels of antibiotics may also now face further complications during co-infection by antibiotic resistant bacteria. In the current situation appropriate and systematic testing of Covid-19 patients presenting with a bacterial co-infection should be conducted in order to choose the correct antibiotic to increase the survival of patients and limit the spread of AMR. The use of rapid diagnostics promoting the use of effective narrow-spectrum antibiotics should be used where possible.

Further reading: JPIAMR
Author(s): Anna Sundin
Effective Surveillance  


Unrestricted financial support by:


Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!